Spyre Therapeutics, Inc. — All Filings
744 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002337 | Mar 27, 2026 | — |
| EFFECT | — | 9999999995-26-000722 | Mar 4, 2026 | — |
| 4 | FORM 4 | 0001636282-26-000028 | Mar 3, 2026 | — |
| 4 | FORM 4 | 0001636282-26-000026 | Mar 3, 2026 | Mar 2, 2026 |
| 144 | — | 0001950047-26-002111 | Mar 3, 2026 | — |
| 144 | — | 0001950047-26-001983 | Mar 2, 2026 | — |
| EFFECT | — | 9999999995-26-000695 | Feb 27, 2026 | — |
| POS AM | POS AM | 0001628280-26-012785 | Feb 27, 2026 | — |
| S-3 | S-3 | 0001628280-26-009814 | Feb 19, 2026 | — |
| S-8 | S-8 | 0001636282-26-000024 | Feb 19, 2026 | — |
| 8-K | 8-K | 0001636282-26-000022 | Feb 19, 2026 | — |
| 10-K | 10-K | 0001636282-26-000020 | Feb 19, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0001214659-26-002024 | Feb 17, 2026 | — |
| 4 | FORM 4 | 0001758363-26-000005 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001779990-26-000002 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001636282-26-000004 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000003 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000002 | Jan 13, 2026 | Jan 9, 2026 |
| 4 | FORM 4 | 0001636282-26-000001 | Jan 13, 2026 | Jan 9, 2026 |
| 8-K | 8-K | 0001193125-26-009894 | Jan 12, 2026 | — |
| 4 | FORM 4 | 0001758363-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001758363-25-000003 | Dec 3, 2025 | Dec 1, 2025 |
| 4 | FORM 4 | 0001636282-25-000106 | Nov 5, 2025 | Nov 3, 2025 |
| 8-K | 8-K | 0001636282-25-000104 | Nov 4, 2025 | — |
| 10-Q | 10-Q | 0001636282-25-000102 | Nov 4, 2025 | Sep 30, 2025 |
| 144 | — | 0001950047-25-008390 | Nov 3, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-100449 | Oct 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-240237 | Oct 15, 2025 | Oct 13, 2025 |
| 424B5 | 424B5 | 0001193125-25-239143 | Oct 14, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-237918 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-237904 | Oct 14, 2025 | — |
| 4 | FORM 4 | 0001636282-25-000095 | Sep 3, 2025 | Sep 2, 2025 |
| S-8 | S-8 | 0001636282-25-000093 | Aug 5, 2025 | — |
| 8-K | 8-K | 0001636282-25-000091 | Aug 5, 2025 | — |
| 10-Q | 10-Q | 0001636282-25-000089 | Aug 5, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0000932471-25-001050 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002469 | Jul 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-141756 | Jun 17, 2025 | — |
| 4 | FORM 4 | 0001636282-25-000069 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000068 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000067 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000066 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000065 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001636282-25-000064 | Jun 2, 2025 | May 29, 2025 |
| 8-K | 8-K | 0001636282-25-000063 | Jun 2, 2025 | May 29, 2025 |
| UPLOAD | — | 0000000000-25-005782 | Jun 2, 2025 | — |
| CORRESP | — | 0001636282-25-000054 | May 21, 2025 | — |
| UPLOAD | — | 0000000000-25-004985 | May 9, 2025 | — |
| 8-K | 8-K | 0001636282-25-000050 | May 8, 2025 | — |
| 10-Q | 10-Q | 0001636282-25-000049 | May 8, 2025 | Mar 31, 2025 |